Godavari Biorefineries Limited, through its biotech unit Sathgen Therapeutics, has secured a patent from the China National Intellectual Property Administration (CNIPA) for its proprietary molecule HYDROXY-1,4-NAPHTHALENEDIONE. This compound belongs to a newly developed class of agents that have shown strong activity against cancer cells and cancer stem cells in laboratory tests.
In early research, the molecule demonstrated effectiveness against several types of cancer, including breast and prostate cancers. The patent strengthens the intellectual property protection for this promising compound in one of the world’s largest pharmaceutical markets.
Dr Sangeeta Srivastava, Executive Director at Godavari Biorefineries, commented, “Our efforts are driven by deep scientific research and the need to address complex medical conditions. Securing this patent in China supports the ongoing development of our lead candidate at Sathgen Therapeutics and our broader work in drug discovery.”
Godavari Biorefineries exports its products to more than 20 countries and maintains collaborations with global research networks. Its biotech division, Sathgen Therapeutics, is focused on developing new therapies for cancer and viral infections. With ongoing clinical studies and international patent coverage, the company continues to strengthen its pipeline of treatments targeting critical global health concerns.
Godavari Biorefineries is a pioneer in bio-based chemicals and renewable fuels, committed to sustainable manufacturing and circular economy principles. The company combines a strong foundation in green chemistry with an expanding presence in life sciences, driven by innovation and long-term impact.
Godavari Biorefineries Limited is among the top ethanol manufacturers in India and a frontrunner in ethanol-based chemical production. The company’s diverse portfolio includes bio-based chemicals, sugar, rectified spirits, ethanol, multiple alcohol grades, and power. GBL is uniquely positioned in the Indian market with an extensive range of bio-based products such as MPO, natural 1,3-butylene glycol, ethyl vinyl ether, and others.
